Name : Mohan Pichuraman (51Y/M)

Date : 01 Jul 2025

Test Asked : Executive Health Checkup - Above 40 Yrs Male With Utsh

Report Status: Complete Report

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL
HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE BOMMASANDRA JIGANI LINK ROAD, JIGANI
WITH UTSH INDUSTRIAL AREA, BENGALURU, KARNATAKA

Report Availability Summary

Note: Please refer to the table below for status of your tests.

13 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE WITH Ready

UTSH
FASTING BLOOD SUGAR(GLUCOSE) Ready

HEMOGRAM Ready

PROSTATE SPECIFIC ANTIGEN (PSA) Ready

COMPLETE URINE ANALYSIS Ready

HBA PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

FT3-FT4-USTSH Ready

VITAMIN D PROFILE Ready

SERUM ALBUMIN-GLOBULIN RATIO Ready

SERUM SGOT-SGPT RATIO Ready

INDIRECT BILIRUBIN Ready

ALKALINE PHOSPHATASE Ready

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE WITH BOMMASANDRA JIGANI LINK ROAD, JIGANI INDUSTRIAL
UTSH AREA, BENGALURU, KARNATAKA --560068

MOBILE NO : 6364084792 PAN ID : HH-89599

DOB : 07/05/1973

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.6 % 0-0.5
LYMPHOCYTE 46.1 % 20-40
LYMPHOCYTES - ABSOLUTE COUNT 3.26 X 10³ / µL 1.0-3.0
NEUTROPHILS 39.9 % 40-80
TOTAL RBC 4.38 X 10^6/µL 4.5-5.5
COMPLETE URINE ANALYSIS
URINARY PROTEIN Trace (15-30 mg/dl) mg/dL Absent
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 131 mg/dL 90-120
HbA1c 6.2 % < 5.7
LIPID
LDL CHOLESTEROL - DIRECT 111 mg/dL < 100
TRIG / HDL RATIO 3.31 Ratio < 3.12
TRIGLYCERIDES 189 mg/dL < 150
RENAL
BUN / SR.CREATININE RATIO 8.84 Ratio 9:1-23:1
EST. GLOMERULAR FILTRATION RATE (eGFR) 88 mL/min/1.73 m2 >= 90
URIC ACID 7.35 mg/dL 4.2 - 7.3
VITAMIN
VITAMIN D TOTAL 17.75 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS
INDUSTRIAL AREA, BENGALURU, KARNATAKA
MALE WITH UTSH --560068
PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME TECHNOLOGY VALUE UNITS

PROSTATE SPECIFIC ANTIGEN (PSA) C.L.I.A 0.5 ng/mL
Bio. Ref. Interval. :-

Normal : < 4.00 ng/ml

Border line : 4.01 to 10.00 ng/ml

Clinical Significance:

Elevated levels of PSA are associated with prostate cancer, but may also be seen with prostatitis (Inflammation of the prostate)
and benign prostatic hyperplasia (BPH). PSA test done along with free PSA provides additional information. Studies have
suggested that the percentage of free PSA in total PSA is lower in patients with prostate cancer than those with benign prostate
hyperplasia.

Specification:

Precision: Intra assay (%CV): 4.38%, Inter assay (%CV): 4.67%; Sensitivity: 0.01 ng/ml

Kit validation references:

Wang MC, Valenzuala LA, Murphy GP, and Chu TM. Purification of a human prostate-specific antigen. Invest. Urol. 1979; 17: 159

Please correlate with clinical conditions.

Method:- TWO SITE SANDWICH IMMUNOASSAY

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path)
Labcode : 0107042908/HCL14
Barcode : DX170229 Page : 1 of 12
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
: HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI INDUSTRIAL
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE AREA, BENGALURU, KARNATAKA --560068
WITH UTSH
PATIENTID : MP21973136
MOBILE NO : 6364084792 PAN ID : HH-89599
DOB : 07/05/1973
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 191 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 57 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.52 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 111 mg/dL < 100
TRIG / HDL RATIO CALCULATED 3.31 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 189 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.4 Ratio 3-5
LDL / HDL RATIO CALCULATED 1.9 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 37.88 mg/dL 5 - 40
NON-HDL CHOLESTEROL CALCULATED 134.2 mg/dL < 160
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
VLDL - Derived from serum Triglyceride values
NHDL - Derived from serum Cholesterol and HDL values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Labcode : 0107042908/HCL14 Dr Syeda Sumaiya MD(Path)

Barcode : DX170229 Page : 2 of 12

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
: HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI INDUSTRIAL
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE AREA, BENGALURU, KARNATAKA --560068
WITH UTSH
PATIENTID : MP21973136
MOBILE NO : 6364084792 PAN ID : HH-89599
DOB : 07/05/1973
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 76.54 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.58 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.47 mg/dL 0-0.9
SGOT / SGPT RATIO CALCULATED 1.15 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 31.4 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.3 U/L < 45
PROTEIN - TOTAL PHOTOMETRY 7.53 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.24 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.29 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.29 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Labcode : 0107042908/HCL14 Dr Syeda Sumaiya MD(Path)

Barcode : DX170229 Page : 3 of 12

 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
REF. BY : HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI INDUSTRIAL
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE AREA, BENGALURU, KARNATAKA --560068
WITH UTSH

PATIENTID : MP21973136
MOBILE NO : 6364084792 PAN ID : HH-89599
DOB : 07/05/1973
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TSH - ULTRASENSITIVE C.L.I.A 4.463 µIU/mL 0.55-4.78
FREE TRIIODOTHYRONINE (FT3) C.L.I.A 3.17 pg/mL 1.7-4.2
FREE THYROXINE (FT4) C.L.I.A 0.99 ng/dL 0.7-1.8

Comments :
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

FT3,FT4 - Competitive Chemi Luminescent Immuno Assay

USTSH - Third Generation Ultrasensitive Chemi Luminescent Immuno Assay

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Labcode : 0107042908/HCL14 Dr Syeda Sumaiya MD(Path)
Barcode : DX170229 Page : 4 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
: HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI INDUSTRIAL
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE AREA, BENGALURU, KARNATAKA --560068
WITH UTSH
PATIENTID : MP21973136
MOBILE NO : 6364084792 PAN ID : HH-89599
DOB : 07/05/1973
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
CALCIUM PHOTOMETRY 9.46 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 7.35 mg/dL 4.2 - 7.3
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.1 mg/dL 7.94 - 20.07
UREA (CALCULATED) CALCULATED 19.47 mg/dL Adult : 17-43
CREATININE - SERUM PHOTOMETRY 1.03 mg/dL 0.72-1.18
UREA / SR.CREATININE RATIO CALCULATED 18.91 Ratio < 52
BUN / SR.CREATININE RATIO CALCULATED 8.84 Ratio 9:1-23:1
Please correlate with clinical conditions.

Method :
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
BUN - Kinetic UV Assay.
UREAC - Derived from BUN Value.
SCRE - Creatinine Enzymatic Method
UR/CR - Derived from UREA and Sr.Creatinine values.
B/CR - Derived from serum Bun and Creatinine values

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Labcode : 0107042908/HCL14 Dr Syeda Sumaiya MD(Path)

Barcode : DX170229 Page : 5 of 12

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS
INDUSTRIAL AREA, BENGALURU, KARNATAKA
MALE WITH UTSH --560068
PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 88 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path)
Labcode : 0107042908/HCL14
Barcode : DX170229 Page : 6 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
: HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE INDUSTRIAL AREA, BENGALURU, KARNATAKA
WITH UTSH --560068

PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME TECHNOLOGY VALUE UNITS

VITAMIN D2 LC-MS/MS 0.32 ng/mL

Method : LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY

VITAMIN D3 LC-MS/MS 17.43 ng/mL

Method : LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY

VITAMIN D TOTAL CALCULATED 17.75 ng/mL

Bio. Ref. Interval. :
Deficiency : <20 ng/mL
Insufficiency : 20-30 ng/mL
Sufficiency : 30-100 ng/mL
Toxicity : >100 ng/mL
Method : Derived from VD2 and VD3 values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 17:46
Report Released on (RRT) : 01 Jul 2025 20:26
Sample Type : SERUM
Labcode : 0107042908/HCL14 Dr Syeda Sumaiya MD(Path)
Barcode : DX170229
Page : 7 of 12
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
: HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE INDUSTRIAL AREA, BENGALURU, KARNATAKA
WITH UTSH --560068

PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c H.P.L.C 6.2 %
Bio. Ref. Interval. :
As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control
5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 131 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 16:25
Report Released on (RRT) : 01 Jul 2025 17:45
Sample Type : EDTA Whole Blood
Labcode : 0107098656/HCL14 Dr.Shalaka MD(Path) Dr.Ishant MD(Path)
Barcode : EE588279
Page : 8 of 12
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE WITH
INDUSTRIAL AREA, BENGALURU, KARNATAKA
UTSH
PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 13.8 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 43.5 % 40.0-50.0
Total RBC HF & EI 4.38 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 99.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 31.5 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 31.7 g/dL 31.5-34.5
Red Cell Distribution Width (RDW - CV) Calculated 13.5 % 11.6-14
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.07 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 39.9 % 40-80
Lymphocytes Percentage Flow Cytometry 46.1 % 20-40
Monocytes Percentage Flow Cytometry 8.1 % 2-10
Eosinophils Percentage Flow Cytometry 4.7 % 1-6
Basophils Percentage Flow Cytometry 0.6 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.6 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.1 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 2.83 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 3.26 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.57 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.04 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.33 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.04 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.007 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 307 X 10³ / µL 150-410
Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
results are rechecked twice and released. Advised clinical correlation.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 16:25

Report Released on (RRT) : 01 Jul 2025 17:45

Sample Type : EDTA Whole Blood
Labcode : 0107098656/HCL14 Dr.Shalaka MD(Path) Dr.Ishant MD(Path)
Barcode : EE588279 Page : 9 of 12
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
REF. BY : HCL
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS MALE INDUSTRIAL AREA, BENGALURU, KARNATAKA
WITH UTSH --560068
PATIENTID : MP21973136
MOBILE NO : 6364084792 PAN ID : HH-89599
DOB : 07/05/1973
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.
Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.01 - 1.003-1.030
PH pH indicator 7 - 5-8
Chemical Examination
URINARY PROTEIN PEI Trace (15-30 mg/dl) mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 16:32
Report Released on (RRT) : 01 Jul 2025 17:44
Sample Type : URINE
Dr.Shalaka MD(Path) Dr.Ishant MD(Path)
Labcode : 0107099292/HCL14
Barcode : DR570660 Page : 10 of 12
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : MOHAN PICHURAMAN (51Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL HCL HEALTHCARE, SEZ CENTER,UNIT NO. 129,
BOMMASANDRA JIGANI LINK ROAD, JIGANI
TEST ASKED : EXECUTIVE HEALTH CHECKUP - ABOVE 40 YRS
INDUSTRIAL AREA, BENGALURU, KARNATAKA
MALE WITH UTSH --560068
PATIENTID : MP21973136 MOBILE NO : 6364084792 DOB : 07/05/1973 PAN ID : HH-89599

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 96.43 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

~~ End of report ~~

Sample Collected on (SCT) : 01 Jul 2025 08:00

Sample Received on (SRT) : 01 Jul 2025 16:26
Report Released on (RRT) : 01 Jul 2025 17:35
Sample Type : FLUORIDE PLASMA
Dr.Shalaka MD(Path) Dr.Ishant MD(Path)
Labcode : 0107098692/HCL14
Barcode : DQ655824 Page : 11 of 12
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of
technologies should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or
damage that may be incurred by any person as a result of presuming the meaning or contents of the report, (b)
any claims of any nature whatsoever arising from or relating to the performance of the requested tests as well
as any claim for indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall
not exceed the total amount of invoice for the services provided and paid for.

EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 12 of 12